Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Misoprostol vs Oxytocin for Bleeding at Cesarean Section
NCT02562300Phase 2Completed
- Sponsor
- Assiut University
- Start
- Jan 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Assiut University. Primary endpoint: Blood loss at 1 year. Started Jan 2014; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02562300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02562300.